RZLT CIK: 1509261

Rezolute, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
millions USD
FY22:
152
FY23:
105
FY24:
129
FY25:
171
FY26:
111
(positive)
Change from FY22 to FY26
millions USD
FY22:
0.32
FY23:
18.8
FY24:
4.08
FY25:
4.35
FY26:
2.34
Total assets
Change from FY22 to FY26
millions USD
FY22:
152
FY23:
124
FY24:
133
FY25:
175
FY26:
113

Liabilities & Equity

(negative)
Change from FY22 to FY26
millions USD
FY22:
2.46
FY23:
5.20
FY24:
9.61
FY25:
11.9
FY26:
11.4
(negative)
Change from FY22 to FY26
millions USD
FY22:
0.49
FY23:
2.35
FY24:
2.13
FY25:
1.45
FY26:
0.74
(positive)
Change from FY22 to FY26
millions USD
FY22:
149
FY23:
116
FY24:
121
FY25:
162
FY26:
101
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
152
FY23:
124
FY24:
133
FY25:
175
FY26:
113

All amounts in millions USD Data source:SEC EDGAR